The expiration of the TRIPS waiver is just one aspect of a broader set of challenges that the industry will need to address.

Bangladesh’s booming pharmaceutical industry sees about 98% of the country’s medicine demands produced locally, while its pharmaceutical companies export to 151 countries. It’s no surprise ...

Bangladesh's transition out of the Least Developed Countries (LDC) bracket to a developing nation will bring several challenges for the pharmaceutical industry, sector insiders fear.

Cord blood preservation. Cancer drugs. Insulin production. Hormones. These are a few of the cutting-edge therapies and medicines being manufactured in Bangladesh, helping build the country’s ...

The government has announced plans to appoint graduate pharmacists in public hospitals for the first time, aiming to enhance the quality of healthcare services across Bangladesh. The announcement was ...

Highlights: Bangladesh produces only 41 of 400 needed APIs, relying on imports for 80% Pharma market is worth $2.92b, ...